General Information of the Compound
Compound ID
CP0007430
Compound Name
IBRUTINIB
    Show/Hide
Synonyms
1X70OSD4VX
CRA-032765
IMBRUVICA
Ibrutinib
Ibrutinib (BTK inhibitor)
Ibrutinib (PCI-32765)
PCI 32765
PCI-32765
PCI-32765 (Ibrutinib)
Pc-32765
UNII-1X70OSD4VX
    Show/Hide
Structure
Formula
C25H24N6O2
Molecular Weight
440.507
Canonical SMILES
Nc1ncnc2n(nc(-c3ccc(Oc4ccccc4)cc3)c12)[C@@H]1CCCN(C1)C(=O)C=C
    Show/Hide
InChI
InChI=1S/C25H24N6O2/c1-2-21(32)30-14-6-7-18(15-30)31-25-22(24(26)27-16-28-25)23(29-31)17-10-12-20(13-11-17)33-19-8-4-3-5-9-19/h2-5,8-13,16,18H,1,6-7,14-15H2,(H2,26,27,28)/t18-/m1/s1
    Show/Hide
InChIKey
XYFPWWZEPKGCCK-GOSISDBHSA-N
CAS
936563-96-1
Physicochemical Property
logP
4.2173
Rotatable Bonds
5
Heavy Atom Count
33
Polar Areas
99.16
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
7
Complexity
33

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 24821094
SID: 49837088
ChEMBL ID
CHEMBL1873475
DrugBank ID
DB09053
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01669, Cytoplasmic tyrosine-protein kinase BMX
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000012 Sf21 Spodoptera frugiperda (Fall armyworm)  1
1
IC50 = 0.4 nM
   TI
   LI
   LO
   TS
CL000013 Sf9 Spodoptera frugiperda (Fall armyworm)  1
1
IC50 = 8 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 0.5 nM
2 IC50 = 0.8 nM
3 IC50 = 1 nM
4 IC50 = 5.8 nM
5 Kd = 1.4 nM
6 Kd = 1.6 nM
Protein ID: PT00922, Epidermal growth factor receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000052 A-431 Homo sapiens (Human)  2
1
EC50 = 49 nM
   TI
   LI
   LO
   TS
2
IC50 = 101 nM
   TI
   LI
   LO
   TS
CL000379 PC-9 Homo sapiens (Human)  1
1
GI50 = 50 nM
   TI
   LI
   LO
   TS
CL000324 NCI-H3255 Homo sapiens (Human)  1
1
GI50 = 110 nM
   TI
   LI
   LO
   TS
CL000077 Ba/F3 Mus musculus (Mouse)  1
1
GI50 = 160 nM
   TI
   LI
   LO
   TS
CL000157 NCI-H1975 Homo sapiens (Human)  1
1
GI50 = 1200 nM
   TI
   LI
   LO
   TS
CL000012 Sf21 Spodoptera frugiperda (Fall armyworm)  1
1
IC50 = 1.7 nM
   TI
   LI
   LO
   TS
CL000013 Sf9 Spodoptera frugiperda (Fall armyworm)  1
1
IC50 = 123 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 0.75 nM
2 IC50 < 1 nM
3 IC50 = 1.2 nM
4 IC50 = 2.5 nM
5 IC50 = 5.3 nM
6 IC50 = 5.6 nM
7 IC50 = 11.2 nM
8 IC50 = 12 nM
9 IC50 = 16 nM
10 IC50 = 30 nM
11 IC50 = 40 nM
12 IC50 = 51 nM
13 IC50 = 96 nM
14 Kd = 3.9 nM
15 Kd = 6.9 nM
Protein ID: PT01204, Receptor-type tyrosine-protein kinase FLT3
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000077 Ba/F3 Mus musculus (Mouse)  1
1
GI50 = 120 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 73 nM
2 IC50 > 1000 nM
Protein ID: PT01308, Tyrosine-protein kinase BTK
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000013 Sf9 Spodoptera frugiperda (Fall armyworm)  11
1
IC50 = 0.3 nM
   TI
   LI
   LO
   TS
2
IC50 = 0.34 nM
   TI
   LI
   LO
   TS
3
IC50 = 0.4 nM
   TI
   LI
   LO
   TS
4
IC50 = 0.5 nM
   TI
   LI
   LO
   TS
5
IC50 = 1 nM
   TI
   LI
   LO
   TS
6
IC50 = 1.8 nM
   TI
   LI
   LO
   TS
7
IC50 = 3.4 nM
   TI
   LI
   LO
   TS
8
IC50 = 3.89 nM
   TI
   LI
   LO
   TS
9
IC50 = 12 nM
   TI
   LI
   LO
   TS
10
IC50 = 17 nM
   TI
   LI
   LO
   TS
11
Ki = 4.8 nM
   TI
   LI
   LO
   TS
CL000012 Sf21 Spodoptera frugiperda (Fall armyworm)  2
1
IC50 = 0.6 nM
   TI
   LI
   LO
   TS
2
IC50 = 0.9 nM
   TI
   LI
   LO
   TS
CL000003 Ramos Homo sapiens (Human)  2
1
IC50 = 3.5 nM
   TI
   LI
   LO
   TS
2
IC50 = 14 nM
   TI
   LI
   LO
   TS
CL000752 PBMC iPSC #1 Homo sapiens (Human)  1
1
IC50 = 4.6 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 0.08 nM
2 IC50 = 0.11 nM
3 IC50 = 0.2 nM
4 IC50 = 0.21 nM
5 IC50 = 0.33 nM
6 IC50 = 0.4 nM
7 IC50 = 0.42 nM
8 IC50 = 0.46 nM
9 IC50 <= 0.5 nM
10 IC50 = 0.5 nM
11 IC50 < 0.5 nM
12 IC50 = 0.54 nM
13 IC50 = 0.6 nM
14 IC50 = 0.64 nM
15 IC50 = 0.7 nM
16 IC50 = 0.72 nM
17 IC50 = 0.8 nM
18 IC50 = 0.89 nM
19 IC50 = 1 nM
20 IC50 = 1.2 nM
21 IC50 = 1.5 nM
22 IC50 = 2.2 nM
23 IC50 = 2.3 nM
24 IC50 = 4 nM
25 IC50 = 5 nM
26 IC50 = 12.9 nM
27 IC50 = 14 nM
28 IC50 = 810 nM
29 IC50 = 1002 nM
30 Kd = 0.64 nM
31 Kd = 1.9 nM
32 Ki = 425 nM
Protein ID: PT01314, Tyrosine-protein kinase ITK/TSK
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000012 Sf21 Spodoptera frugiperda (Fall armyworm)  1
1
IC50 = 5 nM
   TI
   LI
   LO
   TS
CL000001 Jurkat Homo sapiens (Human)  1
1
IC50 = 76.9 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 2.7 nM
2 IC50 = 3 nM
3 IC50 = 4.9 nM
4 IC50 = 10.7 nM
5 IC50 = 13.9 nM
6 IC50 = 33.7 nM
7 IC50 = 99 nM
8 Kd = 57 nM
9 Kd = 63 nM
Protein ID: PT00892, Tyrosine-protein kinase JAK3
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000013 Sf9 Spodoptera frugiperda (Fall armyworm)  3
1
IC50 = 16.1 nM
   TI
   LI
   LO
   TS
2
IC50 < 100 nM
   TI
   LI
   LO
   TS
3
IC50 = 146 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 10 nM
2 IC50 = 16.1 nM
3 IC50 = 22 nM
4 IC50 = 32 nM
5 Kd = 21 nM
6 Kd = 37 nM
Protein ID: PT00875, Tyrosine-protein kinase Lyn
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000013 Sf9 Spodoptera frugiperda (Fall armyworm)  1
1
IC50 = 200 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 16.2 nM
2 IC50 = 200 nM
3 Ki = 14 nM
Protein ID: PT01660, Tyrosine-protein kinase Tec
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 46.7 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 0.5 nM
2 IC50 = 0.57 nM
3 IC50 = 1.86 nM
4 IC50 = 4.34 nM
5 IC50 = 7 nM
6 IC50 = 10 nM
7 IC50 = 77.8 nM
8 Kd = 1 nM
9 Kd = 1.7 nM
Cell Viability or Cytotoxicity Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000002 K-562 Homo sapiens (Human)  1
1
IC50 = 7500 nM
   TI
   LI
   LO
   TS
CL000003 Ramos Homo sapiens (Human)  2
1
IC50 = 1350 nM
   TI
   LI
   LO
   TS
2
IC50 = 6620 nM
   TI
   LI
   LO
   TS
CL000018 HL-60 Homo sapiens (Human)  1
1
IC50 = 8000 nM
   TI
   LI
   LO
   TS
CL000067 HCT 116 Homo sapiens (Human)  1
1
GI50 > 10000 nM
   TI
   LI
   LO
   TS
CL000071 MOLM-13 Homo sapiens (Human)  1
1
GI50 = 1300 nM
   TI
   LI
   LO
   TS
CL000077 Ba/F3 Mus musculus (Mouse)  1
1
GI50 > 10000 nM
   TI
   LI
   LO
   TS
CL000082 HEL Homo sapiens (Human)  1
1
GI50 = 4000 nM
   TI
   LI
   LO
   TS
CL000091 MV4-11 Homo sapiens (Human)  1
1
GI50 = 250 nM
   TI
   LI
   LO
   TS
CL000100 U-937 Homo sapiens (Human)  1
1
GI50 = 8500 nM
   TI
   LI
   LO
   TS
CL000145 NCI-H460 Homo sapiens (Human)  1
1
GI50 > 10000 nM
   TI
   LI
   LO
   TS
CL000174 Raji Homo sapiens (Human)  3
1
IC50 = 14200 nM
   TI
   LI
   LO
   TS
2
IC50 = 19300 nM
   TI
   LI
   LO
   TS
3
IC50 = 19500 nM
   TI
   LI
   LO
   TS
CL000177 U-2932 Homo sapiens (Human)  2
1
GI50 = 4000 nM
   TI
   LI
   LO
   TS
2
GI50 = 4400 nM
   TI
   LI
   LO
   TS
CL000248 OCI-AML-2 Homo sapiens (Human)  1
1
GI50 > 10000 nM
   TI
   LI
   LO
   TS
CL000519 NB4 Homo sapiens (Human)  1
1
GI50 = 3000 nM
   TI
   LI
   LO
   TS
CL000549 Namalwa Homo sapiens (Human)  1
1
GI50 = 6000 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Ibrutinib )
Drug Name Ibrutinib
Company Janssen Biotech; Pharmacyclics
Indication
Mantle cell lymphoma
Approved
B-cell non-hodgkin lymphoma
Phase 3
Diffuse large B-cell lymphoma
Phase 3
Follicular lymphoma
Phase 3
Mantle cell lymphoma
Phase 3
Non-hodgkin lymphoma
Phase 3
Pancreatic cancer
Phase 3
Solid tumour/cancer
Phase 2
Target(s)
Tyrosine-protein kinase BTK (ATK)
Inhibitor
Drug 2 ( Ibrutinib )
Drug Name Ibrutinib
Indication
Coronavirus Disease 2019 (COVID-19)
Phase 2